Aetna selects Swiss Lifestyle to offer international healthcare benefits and services Aetna.

Related StoriesSignostics gets FDA 510k clearance for handheld bladder scannerInnovative single-make use of torque instruments utilize difficult polycarbonate from BayerNeurological examining accessibility and affordability: an interview with Dr Joseph Higgins ‘We are very happy to expand our part in the Swiss Life Network to supply its clients in Singapore with high-quality expatriate worker benefits solutions and providers tailored to meet their specific needs,’ said Derek Goldberg, Aetna International's general manager, Southeast Asia. ‘With this on-the-ground existence in Singapore and our strong global reach, we can provide the personalised, comprehensive support that multinational companies require to make sure their mobile employees have access to quality medical treatment to allow them to maintain good health.since June ‘ Aetna offers been licensed to sell health insurance in Singapore, 2015.

Four of the health care workers had needlestick injuries and were thought to be at significant risk of exposure to Ebola. They were treated with the antiviral drug favipiravir. The drug is authorized in Japan to take care of severe flu, the researchers said. Previous lab tests and experiments in mice suggested the drug could be effective against Ebola, in accordance to background information in the news release. The other four health care workers were considered to be at lower risk for Ebola. They weren’t given the drug, but were monitored instead closely. All eight patients remained healthy more than 42 days of follow-up, the study authors said.Four of the health care workers had needlestick injuries and were thought to be at significant risk of exposure to Ebola. They were treated with the antiviral drug favipiravir. The drug is authorized in Japan to take care of severe flu, the researchers said. Previous lab tests and experiments in mice suggested the drug could be effective against Ebola, in accordance to background information in the news release. The other four health care workers were considered to be at lower risk for Ebola. They weren’t given the drug, but were monitored instead closely. All eight patients remained healthy more than 42 days of follow-up, the study authors said.